J&J settles more defective hip device lawsuits

February 23, 2015

Johnson & Johnson has reached an agreement to settle some 1,400 claims over defective hip replacement devices, a spokeswoman for the health care giant said Monday.

The agreement extends the benefits of a 2013 settlement with plaintiffs involving about 8,000 cases over ASR Hip System devices that cost the company $2.5 billion.

The new extends benefits to patients who replaced their hips from August 2013 through January 2015, said Mindy Tinsley, a spokeswoman for DePuy Synthes, the J&J unit that made the devices that it pulled from the market in 2010.

"By effectively extending the benefits of the previously announced US Settlement Program to an additional group of ASR patients, we are again providing fair compensation to US ASR patients without the delay and uncertainty of protracted litigation," Tinsley said.

The latest is expected to amount to $420 million.

Depuy announced a recall of the all-metal prosthetic in August 2010 following complaints the devices were causing pain and injury. The implants were found to emit metallic debris that can be harmful to patients.

Explore further: US company to pay $2.5B in hip replacement suits (Update)

Related Stories

US company to pay $2.5B in hip replacement suits (Update)

November 19, 2013

Johnson & Johnson said late Tuesday that it will pay $2.5 billion to settle thousands of lawsuits brought by hip replacement patients who accuse the company of selling faulty implants that led to injuries and additional surgeries.

US probes J&J on recalled hip implant marketing (Update)

February 22, 2013

(AP)—U.S. prosecutors are investigating Johnson & Johnson's practices in marketing a line of hip replacements recalled in 2010 because many had to be replaced within a few years—part of a string of more than 30 product ...

AstraZeneca to pay $7.9 million over kickback allegations

February 11, 2015

Pharmaceutical manufacturer AstraZeneca LP will pay $7.9 million to settle allegations that it engaged in a kickback scheme involving the heartburn medicine Nexium, U.S. Justice Department officials said Wednesday.

Recommended for you

Coffee-based colloids for direct solar absorption

March 22, 2019

Solar energy is one of the most promising resources to help reduce fossil fuel consumption and mitigate greenhouse gas emissions to power a sustainable future. Devices presently in use to convert solar energy into thermal ...

EPA adviser is promoting harmful ideas, scientists say

March 22, 2019

The Trump administration's reliance on industry-funded environmental specialists is again coming under fire, this time by researchers who say that Louis Anthony "Tony" Cox Jr., who leads a key Environmental Protection Agency ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.